FPH Relative Valuation - Fisher & Paykel Healthcare Corporation Ltd - Alpha Spread
F

Fisher & Paykel Healthcare Corporation Ltd
ASX:FPH

Watchlist Manager
Fisher & Paykel Healthcare Corporation Ltd
ASX:FPH
Watchlist
Price: 35.37 AUD -0.81% Market Closed
Market Cap: 20.7B AUD
Have any thoughts about
Fisher & Paykel Healthcare Corporation Ltd?
Write Note

Relative Value

The Relative Value of one FPH stock under the Base Case scenario is 30.72 AUD. Compared to the current market price of 35.37 AUD, Fisher & Paykel Healthcare Corporation Ltd is Overvalued by 13%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FPH Relative Value
Base Case
30.72 AUD
Overvaluation 13%
Relative Value
Price
F
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
7
vs Industry
12
Median 3Y
8.9
Median 5Y
9.3
Industry
2.3
Forward
11.3
vs History
0
vs Industry
3
Median 3Y
52.2
Median 5Y
50
Industry
22.4
Forward
64.9
vs History
25
vs Industry
8
Median 3Y
38.1
Median 5Y
40.8
Industry
14.4
vs History
19
vs Industry
3
Median 3Y
96.3
Median 5Y
86.7
Industry
20.8
vs History
26
vs Industry
6
Median 3Y
8.8
Median 5Y
10.3
Industry
2.1
vs History
7
vs Industry
11
Median 3Y
8.9
Median 5Y
9.2
Industry
2.4
Forward
11.3
vs History
4
vs Industry
10
Median 3Y
14.2
Median 5Y
14.7
Industry
4.8
vs History
0
vs Industry
4
Median 3Y
39
Median 5Y
37.2
Industry
12.5
Forward
38.3
vs History
0
vs Industry
6
Median 3Y
39
Median 5Y
37.2
Industry
16.9
Forward
48.1
vs History
23
vs Industry
8
Median 3Y
37.7
Median 5Y
40.9
Industry
14.2
vs History
19
vs Industry
2
Median 3Y
88.4
Median 5Y
83.6
Industry
18.1
vs History
33
vs Industry
9
Median 3Y
7.7
Median 5Y
9.6
Industry
1.8

Multiples Across Competitors

FPH Competitors Multiples
Fisher & Paykel Healthcare Corporation Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NZ
Fisher & Paykel Healthcare Corporation Ltd
ASX:FPH
20.6B AUD 12.9 169.4 63.6 63.6
US
Abbott Laboratories
NYSE:ABT
202.5B USD 5 36.4 20.9 30.9
US
Intuitive Surgical Inc
NASDAQ:ISRG
174B USD 23 83.1 69 86.1
US
Stryker Corp
NYSE:SYK
141.1B USD 6.6 40.9 26.3 32.2
US
Boston Scientific Corp
NYSE:BSX
122.6B USD 8 67 32.5 47
IE
Medtronic PLC
NYSE:MDT
115.4B USD 3.5 29.4 15.3 21.8
US
Becton Dickinson and Co
NYSE:BDX
67.7B USD 3.4 47.9 15.4 27.3
DE
Siemens Healthineers AG
XETRA:SHL
55.4B EUR 2.5 29.5 17 24.8
US
Edwards Lifesciences Corp
NYSE:EW
41.3B USD 6.9 28 22 24
US
IDEXX Laboratories Inc
NASDAQ:IDXX
41.3B USD 10.9 48.8 34.6 38.5
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
39.7B USD 2 25.1 15.1 18.7

See Also

Discover More
Back to Top